NASDAQ : RLMD
Relmada Therapeutics, Inc. — Reports
Healthcare · Biotechnology · United States
Last price 3.58 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 381.88M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports